Evidence map›Paper›PMID 38461325›Full record

ArticleScientific reports2024

Cardiac biopsies reveal differences in transcriptomics between left and right ventricle in patients with or without diagnostic signs of heart failure.

Christoffer Frisk, Sarbashis Das, Maria J Eriksson, Anna Walentinsson, Matthias Corbascio, Camilla Hage, Chanchal Kumar, Mattias Ekström, Eva Maret, Hans Persson and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Characterization of a NovelInternational journal of molecular sciences · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Christoffer FriskDepartment of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University, Box 596, 751 24, Uppsala, Sweden.
Sarbashis DasDepartment of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University, Box 596, 751 24, Uppsala, Sweden.
Maria J ErikssonDepartment of Clinical Physiology, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Anna WalentinssonTranslational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, 431 83, Gothenburg, Sweden.
Matthias CorbascioDepartment of Molecular Medicine and Surgery, Karolinska Institutet, 171 77, Stockholm, Sweden.
Camilla HageDepartment of Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.
Chanchal KumarTranslational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, 431 83, Gothenburg, Sweden.
Mattias EkströmDepartment of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, 182 88, Stockholm, Sweden.
Eva MaretDepartment of Clinical Physiology, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Hans PerssonDepartment of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, 182 88, Stockholm, Sweden.
Cecilia LindeDepartment of Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.
Bengt PerssonDepartment of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University, Box 596, 751 24, Uppsala, Sweden. bengt.persson@icm.uu.se.
Karolinska Institutet · SEKarolinska University Hospital · SEScience for Life Laboratory · SEAstraZeneca (Sweden) · SEDanderyds sjukhus · SEIntegrated Cardio Metabolic Centre · SE

Funding

Science for Life Laboratory-Astra Zeneca; Mölndal, Sweden collaborative grant 1377Vetenskapsrådet 2018-0899Vetenskapsrådet 2020-01978
6 · The paper itself

Abstract

New or mild heart failure (HF) is mainly caused by left ventricular dysfunction. We hypothesised that gene expression differ between the left (LV) and right ventricle (RV) and secondly by type of LV dysfunction. We compared gene expression through myocardial biopsies from LV and RV of patients undergoing elective coronary bypass surgery (CABG). Patients were categorised based on LV ejection fraction (EF), diastolic function and NT-proBNP into pEF (preserved; LVEF ≥ 45%), rEF (reduced; LVEF < 45%) or normal LV function. Principal component analysis of gene expression displayed two clusters corresponding to LV and RV. Up-regulated genes in LV included natriuretic peptides NPPA and NPPB, transcription factors/coactivators STAT4 and VGLL2, ion channel related HCN2 and LRRC38 associated with cardiac muscle contraction, cytoskeleton, and cellular component movement. Patients with pEF phenotype versus normal differed in gene expression predominantly in LV, supporting that diastolic dysfunction and structural changes reflect early LV disease in pEF. DKK2 was overexpressed in LV of HFpEF phenotype, potentially leading to lower expression levels of β-catenin, α-SMA (smooth muscle actin), and enhanced apoptosis, and could be a possible factor in the development of HFpEF. CXCL14 was down-regulated in both pEF and rEF, and may play a role to promote development of HF.

Indexed as

Heart FailureVentricular Dysfunction, LeftBiopsyEchocardiographyGene Expression ProfilingHeart VentriclesHumansStroke VolumeVentricular Function, LeftCardiac biopsyGene expressionHeart failureIschemic heart diseaseLeft ventricular dysfunction

Identifiers

PMID38461325
PMCPMC10924960
OpenAlexW4392619293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.